Rocket Lab Corp current report, 24 August 2021

Full document

Rocket Lab USA, Inc. — Form 8-K Summary

Business context and reporting period

This Form 8-K reports Rocket Lab’s completion of a business combination with Vector Acquisition Corporation. The filing date is August 30, 2021, with the earliest reported event occurring August 24, 2021. Vector domesticated from the Cayman Islands into Delaware on August 24 and changed its name to Vector Acquisition Delaware Corporation. The merger transactions closed on August 25, 2021, after which the surviving company was renamed Rocket Lab USA, Inc.

The transaction made Rocket Lab a publicly traded company on Nasdaq under the symbol RKLB; its warrants trade under RKLBW. This filing does not provide a reporting-period income statement, balance sheet, cash-flow statement, or operating results.

Transaction, capitalization, and liquidity

  • The PIPE financing was completed substantially concurrently with the business combination and provided gross proceeds of $467.0 million through the issuance of 46.7 million shares at $10.00 per share.
  • Immediately after the transaction, 447,919,591 shares of New Rocket Lab common stock were outstanding.
  • The outstanding shares included 362,188,208 shares issued to former Rocket Lab stockholders, 31,031,383 shares issued to former Vector Class A holders, 8,000,000 shares issued to former Vector Class B holders, and 46,700,000 PIPE shares.
  • Vector shareholders redeemed 968,617 Class A ordinary shares before closing.
  • There were warrants to purchase 16,266,666 shares at an exercise price of $11.50 per share, plus Rocket Lab warrants to purchase 891,380 shares at a weighted-average exercise price of approximately $0.29 per share.
  • Outstanding equity awards included options to purchase 17,961,673 shares at a weighted-average exercise price of $1.04, of which 14,253,283 were vested, and 14,903,639 restricted stock units.
  • Rocket Lab also had a pre-existing earnout obligation covering up to 1,915,356 additional shares.
  • The filing does not provide post-closing cash, debt, liquidity, net income, revenue, margins, or cash-flow amounts.

Material changes versus the prior comparable period

  • The transaction converted Vector from a Cayman Islands exempted company into a Delaware corporation and then combined it with Rocket Lab.
  • Rocket Lab’s existing preferred stock converted into common stock, and its equity awards and warrants were adjusted under the merger terms.
  • Rocket Lab became a public company with a substantially expanded share count and $467.0 million of gross PIPE financing proceeds.
  • Former Vector securities were converted into Rocket Lab securities, including common stock, warrants, and units.

Guidance, outlook, risks, and unusual items

  • If Rocket Lab’s common stock closes at or above $20.00 for at least 20 trading days during any 30-consecutive-trading-day period beginning on the 90th day after closing and ending on the 180th day, holders of eligible pre-merger Rocket Lab equity securities may receive up to 32,150,757 earnout shares, subject to the applicable award terms.
  • The company is required to file a resale registration statement for the PIPE shares within 30 days after closing and use reasonable best efforts to have it declared effective as soon as practicable.
  • Potential dilution exists from public warrants, Rocket Lab warrants, options, restricted stock units, the pre-existing earnout obligation, and the performance-based earnout shares.
  • The filing principally addresses transaction completion and changes to security-holder rights, certificates of incorporation, and bylaws; it does not provide operating guidance or management commentary on business performance.

Important facts for investors to verify

  1. Whether the stated post-closing share count reconciles with all outstanding warrants, options, restricted stock units, and earnout obligations.
  2. The timing and effectiveness of the resale registration statement for the 46.7 million PIPE shares.
  3. The actual post-closing cash balance, transaction expenses, debt, and liquidity, which are not disclosed in this filing.
  4. The final terms and potential dilution associated with the 32,150,757 performance-based earnout shares.
  5. Subsequent filings containing Rocket Lab’s financial statements, operating results, risk factors, and management outlook.